Morgan Hill, California: Discovery Biologics R&D facility supporting biologics research, cell line development and specialised pharmacology/efficacy programmes. Facility area: 42,580 sq. ft. as of March 31, 2026.
Facility capabilities include cell line development suites, upstream process development suites, microbial capabilities, molecular biology, downstream processing and analytical laboratories.
Adjacent molecular biology, downstream processing (DSP) and analytical labs
As of March 31, 2026, installed GMP manufacturing capacity is 2.50 KL using single-use bioreactors, supported by upstream process development and quality control capabilities.
Vivarium and laboratory in Morgan Hill
Suites can be dedicated/expanded
Vivarium (rodent studies)
5 wet labs
Active DEA, USDA registration
OLAW assurance for government-funded studies
